Wolverine Trading
SPPI

Wolverine Trading’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Wolverine Trading’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-22,599
Closed -$9.53K – 5363
2022
Q3 		$10K Buy
22,599
+8,421
+59% +$8.27K ﹤0.01% 4451
2022
Q2 		$11K Buy
14,178
+3,969
+39% +$3.5K ﹤0.01% 4313
2022
Q1 		$13K Sell
10,209
-6,986
-41% -$6.43K ﹤0.01% 5289
2021
Q4 		$23K Buy
+17,195
New +$30.7K ﹤0.01% 5492
2021
Q3 		– Sell
-10,829
Closed -$29.6K – 7227
2021
Q2 		$42K Buy
+10,829
New +$37.6K ﹤0.01% 5630
2020
Q4 		– Sell
-24,566
Closed -$101K – 5655
2020
Q3 		$103K Buy
24,566
+3,948
+19% +$15K ﹤0.01% 4128
2020
Q2 		$64K Sell
20,618
-10,884
-35% -$31.7K ﹤0.01% 4263
2020
Q1 		$72K Sell
31,502
-23,557
-43% -$64.5K ﹤0.01% 4143
2019
Q4 		$197K Buy
55,059
+41,709
+312% +$337K ﹤0.01% 4030
2019
Q3 		$118K Buy
+13,350
New +$108K ﹤0.01% 3802
2017
Q4 		– Sell
-29,102
Closed -$409K – 5675
2017
Q3 		$409K Buy
+29,102
New +$263K ﹤0.01% 2864

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wolverine Trading's SPPI Position: Q4 2022 in Review

Wolverine Trading sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2022, closing a stake of 22,599 shares — an estimated $9.53K sold.

Wolverine Trading first reported a position in SPPI in Q3 2017 and held it in 11 quarters. The position peaked at $409K in Q3 2017. 70 funds tracked by Wall St. Rank hold SPPI as of Q4 2022.

  • Wolverine Trading reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2022 after selling out during the quarter.
  • Wolverine Trading sold 22,599 Spectrum Pharmaceuticals Inc shares in Q4 2022, an estimated $9.53K.
  • Wolverine Trading first reported a position in Spectrum Pharmaceuticals Inc in Q3 2017 and held it in 11 quarters.
  • Wolverine Trading's Spectrum Pharmaceuticals Inc position peaked at $409K in Q3 2017.
  • 70 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2022.

Based on Wolverine Trading's 13F filing for Q4 2022, filed 14 Feb 2023.